Blueweave
Colorectal Cancer Therapeutics Market

Colorectal Cancer Therapeutics Market

Colorectal Cancer Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Therapy (Target Therapy, Immunotherapy, Chemotherapy, Others); By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others); Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

  • Published Date: October 2022
  • Report ID: BWC22426
  • Available Format: PDF
  • Page: 313

Report Overview

High incidences of colorectal cancer across the world, increasing awareness about the disease and high mortality rate associated with the cancer, and the launch of novel therapeutics are expected to drive global colorectal cancer therapeutics market at a significant growth rate during the period in analysis.

Global Colorectal Cancer Therapeutics Market - Industry Trends & Forecast Report, 2028

Global Colorectal Cancer Therapeutics Market size was estimated at USD 12.38 billion in 2021. During the forecast period between 2022 and 2028, global colorectal cancer therapeutics market size is expected to grow at a significant CAGR of 7.4% reaching a value of USD 20.16 billion by 2028. Rising frequency of colorectal cancer and the availability of different treatment options are major growth drivers for global colorectal cancer therapeutics market. Colorectal cancer is a malignant tumor on the inner wall of the large intestine. The cancer is caused by abnormal cell proliferation, which can infiltrate and spread to other parts of the body. The most common causes of colorectal cancer are inflammatory bowel disease and genetic inheritance. Lonsurf, CYRAMZA (ramucirumab), TS-1/Teysuno, CPP-1X (cephaloridine hydrochloride), MelCancerVac, Xilonix, and Nintedanib are some of the colorectal cancer therapies in the development. Colorectal cancer can be treated with a variety of treatments, including chemotherapy agents, immunotherapy, and leucovorin (a chemoprotectant).

Colorectal Therapeutics Market

Global Colorectal Cancer Therapeutics Market – Technology Advancements

Colorectal cancer treatment with therapeutics requires a multifaceted approach, which may necessitate the use of a combination treatment involving several medications. Several key market leaders have introduced advanced drugs to address the diverse treatment needs of colorectal cancer. For example, the implementation of newer initiatives aimed at the effective care of colorectal cancer patients is expected to contribute to global growth. Dana-Farber Cancer Institute, a leading cancer treatment and research institution in the United States, announced the establishment of the Young-Onset Colorectal Cancer Centre in April 2019. Colorectal cancer medications have undergone significant R&D advancements since they were first introduced to the public. Since then, several novel therapeutics have been introduced, with encouraging results. In some ways, the global market may be considered overcrowded due to the presence of several major players and the growing influence of comparatively cheaper generics, particularly in chemotherapy. However, the serious nature of colorectal cancer necessitates the use of cutting-edge therapeutics and the rising prevalence necessitate a better treatment outlook for patients. This has resulted in a significant unmet treatment need in the market, which is expected to be one of the other key driving factors for the global colorectal cancer therapeutics market.

Global Colorectal Cancer Therapeutics Market - Industry Trends and Forecasts

Growth Drivers

Increasing awareness about colorectal cancer and therapeutics

The rise in colorectal cancer awareness is a major element driving the growth of the global colorectal cancer therapeutics market. Furthermore, the increasing number of corresponding product introductions for effective colorectal cancer therapy could aid overall market growth during the period in analysis. Also, the introduction of recent efforts aimed at providing better colorectal cancer patient care could contribute to the growth of the market for colorectal cancer therapeutics. Furthermore, high mortality rates, combined with increased global demand for effective cancer treatments, are expected to boost the growth of the colorectal cancer therapeutics market in during the forecast period.

Restraints

High cost and slow adoption rate of therapeutics

Global colorectal cancer therapeutics market growth could be limited by a lack of knowledge among patient population in emerging countries and under developing economies. There is also significant reluctance among people to adopt colorectal cancer drugs in some regions due its high costs.

Impact of COVID -19 on Global Colorectal Cancer Therapeutics Market

The sudden emergence of the COVID-19 pandemic prompted the imposition of strict lockdown measures across countries, causing delays in the import and export of colorectal cancer therapeutics. The global market for colorectal cancer drugs was estimated to fall with a negative CAGR in 2021. The slow decline is primarily due to the COVID-19 outbreak, which has reduced demand for immunocompromised treatments. However, post pandemic and lockdown relaxations, the market is expected to bounce back its pre Covid-19 growth level.

Segmental Coverage

Global colorectal cancer therapeutics market is segmented by target therapy, cancer type, distribution channel, and region. The target therapy segment is further categorized into    immunotherapy, chemotherapy, and others. The global colorectal cancer therapeutics market by cancer type is sub-segmented into colorectal adenocarcinoma, gastrointestinal carcinoid tumors, and others. By distribution channel, the market is further segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. There are five major regions, namely North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, in the global colorectal cancer therapeutics market. Each regional market is further categorized by its major countries.

Regional Insights

Global colorectal cancer therapeutics market by geography is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Because of the rising prevalence of colorectal cancer cases in the region, North America dominates the global market for colorectal cancer therapeutics. Furthermore, the market for colorectal cancer therapeutics in North America is being driven by greater illness awareness and enhanced healthcare infrastructure. Over the next few years, the market for colorectal cancer therapeutics in Asia Pacific (APAC) is forecast to rise rapidly, followed by that in Europe. In the APAC region, China and India could be the fastest expanding markets for colorectal cancer therapeutics.

Competitive Landscape

Prominent players in global colorectal Cancer therapeutics market include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. These companies follow various strategies, including mergers and acquisitions, joint ventures, partnerships, collaborations, and licensing agreements to further enhance their position in global colorectal cancer therapeutics market.

Recent Developments

  • In December 2021 - Natco Pharma launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in India.

  • In December 2021 - the US Food and Drug Administration (US FDA) granted Isofol Medical AB fast track designation for Arfolitixorin (6R-MTHF) for patients with metastatic colorectal cancer.

  • In June 2021 - Bristol Myers Squibb announced the European Commission approval of Opdivo plus Yervoy for the treatment of adult patients with microsatellite instability-high metastatic colorectal cancer. It has been granted marketing authorization for use in all EU member countries as well as Norway, Iceland, and Liechtenstein.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2018–2021

Base Year – 2021

Estimated Year – 2022

Forecast – 2022–2028

Facts Covered

Revenue in USD Billion

Market Coverage

North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East & Africa)

Product/ Service Segmentation

Therapy, Cancer Type, Distribution Channel, Region

Key Players

Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol-Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.

 

 

By Therapy

  • Target Therapy

  • Immunotherapy

  • Chemotherapy

  • Others

By Cancer Type

  • Colorectal Adenocarcinoma

  • Gastrointestinal Carcinoid Tumors

  • Others

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

  • Others

By Region

      • North America

      • Europe

      • Asia Pacific

      • Latin America

      • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation
  3. Executive Summary
  4. Global Colorectal Cancer Therapeutics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    3. Technological Advancement/Recent Development
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  5. Global Colorectal Cancer Therapeutics Market Overview
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
        1. Target Therapy
        2. Immunotherapy
        3. Chemotherapy
        4. Others
      2. By Cancer Type
        1. Colorectal Adenocarcinoma
        2. Gastrointestinal Carcinoid Tumors
        3. Others
      3. By Distribution Channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. The Middle East and Africa
  6. North America Colorectal Cancer Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
      2. By Cancer Type
      3. By Distribution Channel
      4. By Country
        1. United States
        2. Canada
  7. Europe Colorectal Cancer Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
      2. By Cancer Type
      3. By Distribution Channel
      4. By Country
        1. Germany
        2. United Kingdom
        3. Italy
        4. France
        5. Spain
        6. The Netherlands
        7. Belgium
        8. NORDIC Countries
        9. Rest of Europe
  8. The Asia Pacific Colorectal Cancer Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
      2. By Cancer Type
      3. By Distribution Channel
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia & New Zealand
        6. Indonesia
        7. Malaysia
        8. Singapore
        9. Philippines
        10. Vietnam
        11. Rest of Asia Pacific
  9. Latin America Colorectal Cancer Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
      2. By Cancer Type
      3. By Distribution Channel
      4. By Country
        1. Brazil
        2. Mexico
        3. Argentina
        4. Peru
        5. Columbia
        6. Rest of Latin America
  10. The Middle East & Africa Colorectal Cancer Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapy
      2. By Cancer Type
      3. By Distribution Channel
      4. By Country
        1. Saudi Arabia
        2. UAE
        3. South Africa
        4. Qatar
        5. Kuwait
        6. Iran
        7. Nigeria
        8. Kenya
        9. Egypt
        10. Algeria
        11. Morocco
        12. Rest of Middle East & Africa
  11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Merger, Acquisition, Partnership, and others)
  12. Impact of Covid-19 on Global Colorectal Cancer Therapeutics Market
  13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
    1. Accord Healthcare Ltd.
    2. Amgen Inc.
    3. Amneal Pharmaceuticals Inc.
    4. Bayer AG
    5. Biocon Ltd.
    6. Bristol-Myers Squibb Co.
    7. CK Hutchison Holdings Ltd.
    8. Eli Lilly and Co.
    9. F. Hoffmann La Roche Ltd.
    10. Fresenius SE and Co. KGaA
    11. Hetero Drugs Ltd.
    12. Hikma Pharmaceuticals Plc
    13. Merck and Co. Inc.
    14. Ono Pharmaceutical Co. Ltd.
    15. Otsuka Holdings Co. Ltd.
    16. Pfizer Inc.
    17. Sanofi SA
    18. Sun Pharmaceutical Industries Ltd.
    19. Teva Pharmaceutical Industries Ltd.
    20. Viatris Inc.
    21. Other prominent players

 

  1. Key Strategic Recommendations

 

 

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List of Figure

Figure 1        Global Colorectal Cancer Therapeutics Market Segmentation

Figure 2        Global Colorectal Cancer Therapeutics Value Chain Analysis

Figure 3        Company Market Share Analysis, 2021

Figure 4        Global Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 5        Global Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 7        Global Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 8        Global Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 9        Global Colorectal Cancer Therapeutics Market Share, By Region, By Value, 2018–2028

Figure 10       North America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 11       North America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 13       North America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 14       North America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 15       North America Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 16       United States Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 18       United States Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 19       United States Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 20       United States Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 21       Canada Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 23       Canada Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 24       Canada Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 25       Canada Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 26       Europe Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 27       Europe Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 29       Europe Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 30       Europe Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 31       Europe Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 32       Germany Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 34       Germany Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 35       Germany Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 36       Germany Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 37       UK Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 39       UK Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 40       UK Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 41       UK Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 42       Italy Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 44       Italy Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 45       Italy Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 46       Italy Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 47       France Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 49       France Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 50       France Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 51       France Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 52       Spain Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 54       Spain Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 55       Spain Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 56       Spain Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 57       The Netherlands Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 59       The Netherlands Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 60       The Netherlands Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 61       The Netherlands Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 62       Belgium Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 64       Belgium Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 65       Belgium Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 66       Belgium Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 67       NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 69       NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 70       NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 71       NORDIC Countries Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 72       Rest of Europe Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 74       Rest of Europe Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 75       Rest of Europe Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 76       Rest of Europe Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 77       Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 78       Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 80       Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 81       Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 82       Asia-Pacific Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 83       China Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 85       China Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 86       China Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 87       China Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 88       India Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 90       India Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 91       India Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 92       India Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 93       Japan Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 95       Japan Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 96       Japan Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 97       Japan Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 98       South Korea Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 100     South Korea Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 101     South Korea Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 102     South Korea Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 103     Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 105     Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 106     Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 107     Australia & New Zealand Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 108     Indonesia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 110     Indonesia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 111     Indonesia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 112     Indonesia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 113     Malaysia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 115     Malaysia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 116     Malaysia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 117     Malaysia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 118     Singapore Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 120     Singapore Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 121     Singapore Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 122     Singapore Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 123     Philippines Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 125     Philippines Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 126     Philippines Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 127     Philippines Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 128     Vietnam Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 130     Vietnam Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 131     Vietnam Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 132     Vietnam Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 133     Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 135     Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 136     Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 137     Rest of Asia Pacific Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 138     Latin America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 139     Latin America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 141     Latin America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 142     Latin America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 143     Latin America Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 144     Brazil Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 146     Brazil Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 147     Brazil Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 148     Brazil Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 149     Mexico Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 151     Mexico Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 152     Mexico Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 153     Mexico Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 154     Argentina Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 156     Argentina Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 157     Argentina Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 158     Argentina Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 159     Peru Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 161     Peru Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 162     Peru Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 163     Peru Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 164     Colombia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 166     Colombia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 167     Colombia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 168     Colombia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 169     Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 171     Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 172     Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 173     Rest of Latin America Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 174     Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 175     Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 177     Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 178     Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 179     Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Country, By Value, 2018–2028

Figure 180     Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 182     Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 183     Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 184     Saudi Arabia Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 185     UAE Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 187     UAE Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 188     UAE Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 189     UAE Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 190     Qatar Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 192     Qatar Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 193     Qatar Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 194     Qatar Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 195     Kuwait Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 197     Kuwait Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 198     Kuwait Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 199     Kuwait Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 200     Iran Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 202     Iran Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 203     Iran Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 204     Iran Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 205     South Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 207     South Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 208     South Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 209     South Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 210     Nigeria Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 212     Nigeria Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 213     Nigeria Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 214     Nigeria Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 215     Kenya Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 217     Kenya Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 218     Kenya Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 219     Kenya Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 220     Egypt Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 222     Egypt Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 223     Egypt Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 224     Egypt Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 225     Morocco Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 227     Morocco Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 228     Morocco Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 229     Morocco Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 230     Algeria Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 232     Algeria Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 233     Algeria Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 234     Algeria Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 235     Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Value (USD Billion), 2018–2028

Figure 236     Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Therapy, By Value, 2018–2028

Figure 237     Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Cancer Type, By Value, 2018–2028

Figure 238     Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Share, By Distribution Channel, By Value, 2018–2028

 

List of Tables

 

Table 1         Global Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 2         Global Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 3         Global Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 4         North America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 5         North America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 7         North America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 8         North America Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 9         United States Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 10        United States Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 11        United States Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 13        Canada Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 14        Canada Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 15        Canada Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 16        Europe Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 18        Europe Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 19        Europe Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 20        Europe Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 21        Germany Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 23        Germany Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 24        Germany Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 25        UK Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 26        UK Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 27        UK Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 29        Italy Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 30        Italy Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 31        Italy Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 32        France Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 33        France Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 34        France Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 35        Spain Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 36        Spain Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 37        Spain Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 38        The Netherlands Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 39        The Netherlands Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 40        The Netherlands Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 41        Belgium Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 42        Belgium Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 43        Belgium Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 44        NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 45        NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 46        NORDIC Countries Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 47        Rest of Europe Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 48        Rest of Europe Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 49        Rest of Europe Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 50        Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 51        Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 52        Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 53        Asia-Pacific Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 54        China Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 55        China Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 56        China Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 57        India Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 58        India Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 59        India Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 60        Japan Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 61        Japan Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 62        Japan Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 63        South Korea Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 64        South Korea Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 65        South Korea Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 66        Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 67        Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 68        Australia & New Zealand Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 69        Indonesia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 70        Indonesia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 71        Indonesia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 72        Malaysia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 73        Malaysia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 74        Malaysia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 75        Singapore Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 76        Singapore Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 77        Singapore Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 78        Philippines Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 79        Philippines Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 80        Philippines Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 81        Vietnam Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 82        Vietnam Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 83        Vietnam Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 84        Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 85        Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 86        Rest of Asia Pacific Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 87        Latin America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 88        Latin America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 89        Latin America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 90        Latin America Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 91        Brazil Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 92        Brazil Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 93        Brazil Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 94        Mexico Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 95        Mexico Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 96        Mexico Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 97        Argentina Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 98        Argentina Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 99        Argentina Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 100      Peru Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 101      Peru Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 102      Peru Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 103      Colombia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 104      Colombia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 105      Colombia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 106      Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 107      Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 108      Rest of Latin America Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 109      Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 110      Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 111      Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 112      Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Country, By Value, 2018–2028

Table 113      Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 114      Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 115      Saudi Arabia Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 116      UAE Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 117      UAE Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 118      UAE Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 119      Qatar Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 120      Qatar Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 121      Qatar Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 122      Kuwait Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 123      Kuwait Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 124      Kuwait Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 125      Iran Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 126      Iran Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 127      Iran Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 128      South Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 129      South Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 130      South Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 131      Nigeria Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 132      Nigeria Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 133      Nigeria Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 134      Kenya Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 135      Kenya Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 136      Kenya Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 137      Egypt Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 138      Egypt Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 139      Egypt Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 140      Morocco Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 141      Morocco Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 142      Morocco Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 143      Algeria Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 144      Algeria Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 145      Algeria Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 146      Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Therapy, By Value, 2018–2028

Table 147      Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Cancer Type, By Value, 2018–2028

Table 148      Rest of Middle East & Africa Colorectal Cancer Therapeutics Market Size, By Distribution Channel, By Value, 2018–2028

Table 149      Accord Healthcare Ltd. Company Overview

Table 150      Accord Healthcare Ltd. Financial Overview

Table 151      Amgen Inc. Company Overview

Table 152      Amgen Inc. Financial Overview

Table 153      Amneal Pharmaceuticals Inc. Company Overview

Table 154      Amneal Pharmaceuticals Inc. Financial Overview

Table 155      Bayer AG Company Overview

Table 156      Bayer AG Financial Overview

Table 157      Biocon Ltd. Company Overview

Table 158      Biocon Ltd. Financial Overview

Table 159      Bristol-Myers Squibb Co. Company Overview

Table 160      Bristol-Myers Squibb Co. Financial Overview

Table 161      CK Hutchison Holdings Ltd. Company Overview

Table 162      CK Hutchison Holdings Ltd. Financial Overview

Table 163      Eli Lilly and Co. Company Overview

Table 164      Eli Lilly and Co. Financial Overview

Table 165      F. Hoffmann La Roche Ltd. Company Overview

Table 166      F. Hoffmann La Roche Ltd. Financial Overview

Table 167      Fresenius SE and Co. KGaA Company Overview

Table 168      Fresenius SE and Co. KGaA Financial Overview

Table 169      Hetero Drugs Ltd. Company Overview

Table 170      Hetero Drugs Ltd. Financial Overview

Table 171      Hikma Pharmaceuticals Plc Company Overview

Table 172      Hikma Pharmaceuticals Plc Financial Overview

Table 173      Merck and Co. Inc. Company Overview

Table 174      Merck and Co. Inc. Financial Overview

Table 175      Ono Pharmaceutical Co. Ltd. Company Overview

Table 176      Ono Pharmaceutical Co. Ltd. Financial Overview

Table 177      Otsuka Holdings Co. Ltd. Company Overview

Table 178      Otsuka Holdings Co. Ltd. Financial Overview

Table 179      Pfizer Inc. Company Overview

Table 180      Pfizer Inc. Financial Overview

Table 181      Sanofi SA Company Overview

Table 182      Sanofi SA Financial Overview

Table 183      Sun Pharmaceutical Industries Ltd. Company Overview

Table 184      Sun Pharmaceutical Industries Ltd. Financial Overview

Table 185      Teva Pharmaceutical Industries Ltd. Company Overview

Table 186      Teva Pharmaceutical Industries Ltd. Financial Overview

Table 187      Viatris Inc. Company Overview

Table 188      Viatris Inc. Financial Overview

Market Segmentation

By Therapy

  • Target Therapy
  • Immunotherapy
  • Chemotherapy
  • Others

 

By Cancer Type

  • Colorectal Adenocarcinoma
  • Gastrointestinal Carcinoid Tumors
  • Others

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

By Region

      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.